Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2006 1
2008 1
2009 1
2015 2
2016 1
2017 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants. Caplin ME, et al. Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2. Ann Oncol. 2015. PMID: 25646366 Free article. Review.
As there is a paucity of randomized studies, this expert consensus document represents an initiative by the European Neuroendocrine Tumor Society to provide guidance on their management. PATIENTS AND METHODS: Bibliographical searches were carried out in PubMed for the term …
As there is a paucity of randomized studies, this expert consensus document represents an initiative by the European Neuroendocrine Tumor …
Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
Prinzi N, Rossi RE, Proto C, Leuzzi G, Raimondi A, Torchio M, Milione M, Corti F, Colombo E, Prisciandaro M, Cascella T, Spreafico C, Beninato T, Coppa J, Lo Russo G, Di Bartolomeo M, de Braud F, Pusceddu S. Prinzi N, et al. Clin Lung Cancer. 2021 May;22(3):161-169. doi: 10.1016/j.cllc.2020.12.004. Epub 2020 Dec 17. Clin Lung Cancer. 2021. PMID: 33618994 Review.
Lung carcinoids represent only 1% to 5% of all lung malignancies, but their incidence has significantly increased over the past 30 years. Surgery is the reference standard of treatment for lung carcinoids with locoregional disease. For advanced or unresect …
Lung carcinoids represent only 1% to 5% of all lung malignancies, but their incidence has significantly increased over the pas …
Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM. Wolin EM. Chest. 2017 May;151(5):1141-1146. doi: 10.1016/j.chest.2016.06.018. Epub 2016 Jun 29. Chest. 2017. PMID: 27373769 Free article. Review.
Inconsistencies between guideline recommendations for systemic therapies, especially for chemotherapy, result in a lack of consensus on a standardized treatment for unresectable disease. ...Increased awareness, prompt diagnosis, and additional adequately powered con …
Inconsistencies between guideline recommendations for systemic therapies, especially for chemotherapy, result in a lack of consensus …
Primary carcinoid tumors of the lung: a role for radiotherapy.
Mackley HB, Videtic GM. Mackley HB, et al. Oncology (Williston Park). 2006 Nov;20(12):1537-43; discussion 1544-5, 1549. Oncology (Williston Park). 2006. PMID: 17153907 Free article. Review.
Primary neuroendocrine neoplasms of the lung represent a clinical spectrum of tumors ranging from the relatively benign and slow-growing typical carcinoid to the highly aggressive small-cell lung carcinoma. ...Definitive radiation is warranted in unresecta …
Primary neuroendocrine neoplasms of the lung represent a clinical spectrum of tumors ranging from the relatively benign and slow-grow …
Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations.
Wolin EM. Wolin EM. Oncologist. 2015 Oct;20(10):1123-31. doi: 10.1634/theoncologist.2015-0198. Epub 2015 Aug 25. Oncologist. 2015. PMID: 26306904 Free PMC article. Review.
Neuroendocrine tumors (NET) of the lung represent approximately 25% of all primary lung tumors and can be classified as low grade (typical carcinoids), intermediate grade (atypical carcinoids), or high grade (large cell neuroendocrine carcinoma or small cell lung …
Neuroendocrine tumors (NET) of the lung represent approximately 25% of all primary lung tumors and can be classified as low gr …
Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.
Srirajaskanthan R, Toumpanakis C, Karpathakis A, Marelli L, Quigley AM, Dusmet M, Meyer T, Caplin ME. Srirajaskanthan R, et al. Lung Cancer. 2009 Jul;65(1):68-73. doi: 10.1016/j.lungcan.2008.10.025. Epub 2008 Dec 12. Lung Cancer. 2009. PMID: 19070398
Histological diagnosis from our department was available for 39 patients, with the remainder having had histological assessment performed previously. Typical carcinoid was present in 25 cases, atypical in 9 cases, large cell neuroendocrine carcinoma in 4 and 1 case of smal …
Histological diagnosis from our department was available for 39 patients, with the remainder having had histological assessment performed pr …
Radiation therapy in the management of patients with malignant carcinoid tumors.
Chakravarthy A, Abrams RA. Chakravarthy A, et al. Cancer. 1995 Mar 15;75(6):1386-90. doi: 10.1002/1097-0142(19950315)75:6<1386::aid-cncr2820750622>3.0.co;2-u. Cancer. 1995. PMID: 7533655
BACKGROUND: The purpose of this study was to analyze the effectiveness of radiotherapy for symptomatic, metastatic, and/or unresectable carcinoid tumors. METHODS: From 1975 to 1991, 18 patients with histologically proven carcinoid tumors, including 7 with sym …
BACKGROUND: The purpose of this study was to analyze the effectiveness of radiotherapy for symptomatic, metastatic, and/or unresectable …